跳至主要内容
临床试验/NCT01730807
NCT01730807已完成不适用

IntellaTip MiFi XP Ablation Catheters First in Human Use Trial

Boston Scientific Corporation1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Acute Procedural Success

研究概览

简要总结

A study to assess the performance of a new catheter design for the treatment of Atrial Flutter.

详细描述

A prospective, non-blinded, single arm, single center study designed to assess the performance of the IntellaTip MiFi XP Ablation Catheter for the treatment of recurrent or sustained type I atrial Flutter.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 or older
  • •indicated for ablation for Atrial Flutter

排除标准

  • •Recent MI/cardiac revascularization
  • •Prosthetic Valves
  • •recent ablation for atrial flutter
  • •atrial flutter with reversible cause
  • •Class IV HF

研究组 & 干预措施

IntellaTip XP MiFi

Experimental

Patients with Atrial Flutter will receive ablation treatment with the IntellaTip MiFi XP catheter

干预措施: IntellaTip MiFi XP Catheter (Device)

结局指标

主要结局

Acute Procedural Success

时间窗: one day

The Demonstration of bi-directional isthmus block at the end of the ablation procedure

次要结局

  • Complication Rate at procedure(7 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验